James Parsons - Sernova Corp Director
| SEOVF Stock | USD 0.33 0.01 3.13% |
Director
Mr. James T. Parsons is Director of Sernova Corporationration Mr. James T. Parsons is currently Chief Financial Officer of Trillium Therapeutics Inc. since August 2011, recently listing it on the NASDAQ Capital Market. From 2010 to May 2013 he was Vice President Finance and Corporationrationrate Secretaryat Diamedica Inc. Mr. Parsons was Chief Financial Officer and Corporationrationrate Secretary of Amorfix Life Sciences Ltd.from 2005 to 2010 where he led the generation of the first revenues from a commercial diagnostic service. Mr.Parsons has a broad background in the life sciences industry across therapeutics, diagnostics and device companies and over 25 years of financial management experience since 2012.
| Tenure | 12 years |
| Phone | 519 858 5184 |
| Web | https://www.sernova.com |
James Parsons Latest Insider Activity
Tracking and analyzing the buying and selling activities of James Parsons against Sernova Corp otc stock is an integral part of due diligence when investing in Sernova Corp. James Parsons insider activity provides valuable insight into whether Sernova Corp is net buyers or sellers over its current business cycle. Note, Sernova Corp insiders must abide by specific rules, including filing SEC forms every time they buy or sell Sernova Corp'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
James Parsons over a month ago Acquisition by James Parsons of 16773 shares of DiaMedica Therapeutics at 3.58 subject to Rule 16b-3 | ||
James Parsons over three months ago Acquisition by James Parsons of 21428 shares of DiaMedica Therapeutics subject to Rule 16b-3 | ||
James Parsons over six months ago DiaMedica Therapeutics exotic insider transaction detected |
Sernova Corp Management Efficiency
The company has return on total asset (ROA) of (0.3759) % which means that it has lost $0.3759 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6454) %, meaning that it generated substantial loss on money invested by shareholders. Sernova Corp's management efficiency ratios could be used to measure how well Sernova Corp manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Baowen Dong | China Pharma Holdings | 72 | |
| Emmanuel Caeymaex | Journey Medical Corp | 46 | |
| Matthew Fust | Journey Medical Corp | 53 | |
| Katsuhiko Machida | Shionogi Co | 71 | |
| William Ringo | Journey Medical Corp | 72 | |
| Frederick Craves | Journey Medical Corp | 72 | |
| Yingwen Zhang | China Pharma Holdings | 68 | |
| Paul Hastings | Pacira Pharmaceuticals | 58 | |
| Scott LLB | Lucy Scientific Discovery | 54 | |
| Gene Bennett | China Pharma Holdings | 66 | |
| Keiichi Ando | Shionogi Co | 66 | |
| Teppei Mogi | Shionogi Co | 59 | |
| Andreas Wicki | Pacira Pharmaceuticals | 59 | |
| Mark McDade | Journey Medical Corp | 62 | |
| John Longenecker | Pacira Pharmaceuticals | 70 | |
| Mark Froimson | Pacira Pharmaceuticals | 57 | |
| Kenji Matsuo | Shionogi Co | N/A | |
| Gary Pace | Pacira Pharmaceuticals | 70 | |
| Dennis Winger | Pacira Pharmaceuticals | 68 | |
| Yvonne Greenstreet | Pacira Pharmaceuticals | 55 | |
| Heung Tsui | China Pharma Holdings | 56 | |
Management Performance
| Return On Equity | -0.65 | |||
| Return On Asset | -0.38 |
Sernova Corp Leadership Team
Elected by the shareholders, the Sernova Corp's board of directors comprises two types of representatives: Sernova Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sernova. The board's role is to monitor Sernova Corp's management team and ensure that shareholders' interests are well served. Sernova Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sernova Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ralph Deiterding, CFO | ||
| Douglas Maret, Chief Officer | ||
| Bruce Weber, Director | ||
| Philip Toleikis, CEO and President and Director | ||
| James Parsons, Director | ||
| Ray Matthews, IR Contact Officer | ||
| Jeffrey Bacha, Independent Director | ||
| CA CA, Chief Officer | ||
| Scott Langille, CFO | ||
| Sean Hodgins, CFO | ||
| Frank Holler, Director | ||
| Christopher Barnes, VP Relations | ||
| Frank MBA, Ex Chairman | ||
| BA MSc, CEO Pres |
Sernova Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Sernova Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.65 | |||
| Return On Asset | -0.38 | |||
| Current Valuation | 141.77 M | |||
| Shares Outstanding | 303.33 M | |||
| Shares Owned By Insiders | 2.20 % | |||
| Shares Owned By Institutions | 0.04 % | |||
| Price To Earning | (14.55) X | |||
| Price To Book | 5.69 X | |||
| EBITDA | (23.86 M) | |||
| Net Income | (24.42 M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sernova Corp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sernova Corp's short interest history, or implied volatility extrapolated from Sernova Corp options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sernova Corp. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Sernova OTC Stock analysis
When running Sernova Corp's price analysis, check to measure Sernova Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sernova Corp is operating at the current time. Most of Sernova Corp's value examination focuses on studying past and present price action to predict the probability of Sernova Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sernova Corp's price. Additionally, you may evaluate how the addition of Sernova Corp to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |